HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ping Yu Selected Research

Prostatic Neoplasms (Prostate Cancer)

11/2021Starch Capped Atomically Thin CuS Nanocrystals for Efficient Photothermal Therapy.
1/2014Comparative RNA-seq analysis reveals potential mechanisms mediating the conversion to androgen independence in an LNCaP progression cell model.
6/2013Near-infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases.
1/2013Tissue damage-associated "danger signals" influence T-cell responses that promote the progression of preneoplasia to cancer.
10/2009Targeting lymphotoxin-mediated negative selection to prevent prostate cancer in mice with genetic predisposition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ping Yu Research Topics

Disease

85Neoplasms (Cancer)
01/2024 - 12/2002
23Infections
03/2024 - 04/2003
18Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2023 - 12/2010
15Inflammation (Inflammations)
01/2023 - 02/2007
14Congenital Heart Defects (Congenital Heart Defect)
12/2023 - 01/2018
13Neoplasm Metastasis (Metastasis)
01/2024 - 08/2007
10Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 01/2013
10Obesity
01/2024 - 12/2010
9Hypoxia (Hypoxemia)
01/2024 - 05/2012
8Lung Neoplasms (Lung Cancer)
08/2022 - 11/2011
8Fibrosis (Cirrhosis)
01/2022 - 05/2009
8Type 2 Diabetes Mellitus (MODY)
01/2021 - 03/2009
8Brain Ischemia (Cerebral Ischemia)
06/2020 - 05/2008
8Carcinoma (Carcinomatosis)
07/2012 - 01/2006
7Insulin Resistance
01/2024 - 01/2009
7Pathologic Processes
01/2024 - 11/2012
7Breast Neoplasms (Breast Cancer)
01/2022 - 12/2003
7Ischemia
02/2021 - 12/2010
5Adenocarcinoma
01/2023 - 10/2009
5Wounds and Injuries (Trauma)
01/2022 - 10/2011
5Prostatic Neoplasms (Prostate Cancer)
11/2021 - 10/2009
5Hypertension (High Blood Pressure)
01/2021 - 01/2013
5Hepatocellular Carcinoma (Hepatoma)
01/2021 - 09/2009
5Vomiting
01/2020 - 11/2009
4Pain (Aches)
03/2024 - 02/2007
4Arthritis (Polyarthritis)
03/2024 - 02/2007
4Dehydration (Water Stress)
12/2023 - 01/2012
4Airway Remodeling
10/2023 - 01/2016
4Myocardial Infarction
01/2023 - 05/2009
4Nausea
01/2020 - 11/2009
4Stomach Neoplasms (Stomach Cancer)
06/2017 - 01/2013
4Autoimmune Diseases (Autoimmune Disease)
07/2016 - 11/2005
3Hemorrhage
03/2024 - 01/2013
3Osteoporosis
02/2024 - 09/2011
3Hyperglycemia
01/2024 - 08/2005
3Tinnitus
06/2023 - 06/2012
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2023 - 01/2020
3Reperfusion Injury
01/2023 - 01/2019
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2023 - 10/2006
3Heart Failure
11/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

36Proteins (Proteins, Gene)FDA Link
12/2023 - 12/2003
14AntigensIBA
01/2021 - 12/2002
12Biomarkers (Surrogate Marker)IBA
03/2024 - 09/2010
12Glucose (Dextrose)FDA LinkGeneric
01/2024 - 03/2009
12Messenger RNA (mRNA)IBA
08/2023 - 04/2005
9LipidsIBA
01/2024 - 08/2005
9DNA (Deoxyribonucleic Acid)IBA
07/2019 - 04/2005
8LigandsIBA
01/2021 - 11/2005
8AntibodiesIBA
11/2020 - 05/2009
8CytokinesIBA
01/2020 - 03/2005
7EnzymesIBA
01/2023 - 01/2006
7Cisplatin (Platino)FDA LinkGeneric
01/2021 - 10/2006
7micaIBA
01/2019 - 08/2006
6MetalsIBA
03/2024 - 01/2019
6RNA (Ribonucleic Acid)IBA
12/2023 - 10/2011
6Gefitinib (Iressa)FDA Link
11/2021 - 01/2018
6Ascorbic Acid (Vitamin C)FDA LinkGeneric
08/2021 - 05/2008
6Neoplasm Antigens (Tumor Antigens)IBA
04/2012 - 12/2002
5epimedii flavoneIBA
02/2024 - 01/2019
5Insulin (Novolin)FDA Link
01/2024 - 01/2009
5Triglycerides (Triacylglycerol)IBA
01/2024 - 01/2016
5Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
12/2023 - 01/2018
5Peptides (Polypeptides)IBA
12/2023 - 06/2005
5Therapeutic UsesIBA
01/2023 - 01/2010
5ErbB Receptors (EGF Receptor)IBA
12/2022 - 01/2015
5VaccinesIBA
07/2022 - 02/2010
5salicylhydroxamic acid (SHAM)IBA
01/2022 - 05/2009
5CholesterolIBA
04/2021 - 05/2009
5Retinaldehyde (Retinal)IBA
02/2021 - 01/2017
5Immunoglobulin G (IgG)IBA
11/2020 - 10/2009
4oxidized low density lipoproteinIBA
01/2024 - 01/2012
4Long Noncoding RNAIBA
12/2023 - 01/2019
46-methyladenineIBA
10/2023 - 01/2023
4Sirtuin 1IBA
01/2023 - 07/2015
4AntioxidantsIBA
01/2023 - 10/2013
4PlatinumIBA
01/2023 - 12/2010
4MicroRNAs (MicroRNA)IBA
11/2022 - 01/2013
4Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2022 - 06/2018
4Antineoplastic Agents (Antineoplastics)IBA
06/2022 - 07/2019
4VancomycinFDA LinkGeneric
08/2021 - 01/2017
4Anti-Bacterial Agents (Antibiotics)IBA
08/2021 - 01/2017
4Interleukin-6 (Interleukin 6)IBA
08/2021 - 06/2016
4Caspase 3 (Caspase-3)IBA
07/2021 - 03/2015
4Neuroprotective AgentsIBA
02/2021 - 01/2017
4Alanine Transaminase (SGPT)IBA
01/2021 - 04/2015
4Doxorubicin (Adriamycin)FDA LinkGeneric
11/2017 - 05/2013
4Interleukin-15 (Interleukin 15)IBA
11/2014 - 12/2010
4Lymphotoxin-alpha (Lymphotoxin)IBA
02/2010 - 06/2002
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2024 - 03/2014
3CopperIBA
01/2024 - 02/2019
3SeleniumIBA
01/2024 - 11/2019
3SalicylatesIBA
06/2023 - 06/2012
3Irinotecan (Camptosar)FDA LinkGeneric
01/2023 - 10/2006
3AcidsIBA
10/2022 - 12/2010

Therapy/Procedure

41Therapeutics
03/2024 - 01/2006
26Drug Therapy (Chemotherapy)
12/2023 - 12/2003
7Immunotherapy
01/2023 - 02/2004
5Radiotherapy
12/2023 - 05/2005
5Adjuvant Chemotherapy
12/2020 - 01/2013
3Electrodes (Electrode)
06/2023 - 05/2012